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Abstract
Elucidating the complex evolutionary armory that mosquitoes deploy against insecti-
cides is crucial to maintain the effectiveness of insecticide-based interventions. Here, 
we deciphered the role of a 6.5-kb structural variation (SV) in driving cytochrome 
P450-mediated pyrethroid resistance in the malaria vector, Anopheles funestus. 
Whole-genome pooled sequencing detected an intergenic 6.5-kb SV between dupli-
cated CYP6P9a/b P450s in pyrethroid-resistant mosquitoes through a translocation 
event. Promoter analysis revealed a 17.5-fold higher activity (p < .0001) for the SV− 
carrying fragment than the SV− free one. Quantitative real-time PCR expression pro-
filing of CYP6P9a/b for each SV genotype supported its role as an enhancer because 
SV+/SV+ homozygote mosquitoes had a significantly greater expression for both 
genes than heterozygotes SV+/SV− (1.7- to 2-fold) and homozygotes SV−/SV− (4-to 
5-fold). Designing a PCR assay revealed a strong association between this SV and 
pyrethroid resistance (SV+/SV+ vs. SV−/SV−; odds ratio [OR] = 2,079.4, p < .001). 
The 6.5-kb SV is present at high frequency in southern Africa (80%–100%) but ab-
sent in East/Central/West Africa. Experimental hut trials revealed that homozygote 
SV mosquitoes had a significantly greater chance to survive exposure to pyrethroid-
treated nets (OR 27.7; p < .0001) and to blood feed than susceptible mosquitoes. 
Furthermore, mosquitoes homozygote-resistant at the three loci (SV+/CYP6P9a_R/
CYP6P9b_R) exhibited a higher resistance level, leading to a far superior ability to 
survive exposure to nets than those homozygotes susceptible at the three loci, re-
vealing a strong additive effect. This study highlights the important role of structural 
variations in the development of insecticide resistance in malaria vectors and their 
detrimental impact on the effectiveness of pyrethroid-based nets.
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1  | INTRODUC TION
Malaria control programmes rely heavily on insecticide-based 
vector control interventions including the mass distribution of 
long-lasting insecticidal nets (LLINs) impregnated with pyrethroids 
(Bhatt et al., 2015). Unfortunately, the increased use of LLINs 
over the years has contributed, among other factors, to the se-
lection of pyrethroid-resistant mosquitoes (Barnes, et al., 2017). 
The widespread resistance to insecticides in major malaria vec-
tors including Anopheles gambiae and Anopheles funestus is prob-
ably one of the main factors behind the recent increase in malaria 
cases across the world, from 214 million in 2015 to 219 million 
in 2017 (WHO, 2018) or the stagnation of such control efforts 
(WHO, 2019). Such growing resistance reports call for urgent ac-
tion to implement suitable resistance management strategies to 
reduce the impact on the effectiveness of current and future in-
secticide-based tools, as highlighted by the WHO global plan for 
insecticide resistance management (WHO, 2012). Elucidating the 
molecular and genetic basis of insecticide resistance is a key step 
to understanding factors driving resistance and to design diagnos-
tic tools to better detect and track the spread of such resistance in 
the field as well as better assess its impact on the effectiveness of 
control tools (WHO, 2012).
The two major insecticide resistance mechanisms are tar-
get-site resistance and metabolic resistance. Target-site resistance 
mechanisms including knockdown resistance (kdr) in the sodium 
channel gene are well characterized in most mosquito species 
(Martinez-Torres et al., 1998). However, for other species such 
as A. funestus, kdr is absent with resistance mainly conferred by 
metabolic resistance (Irving & Wondji, 2017). Three classes of en-
zymes mainly confer metabolic resistance, notably cytochrome 
P450 monooxygenases (P450s), glutathione S-transferases and 
esterases (Hemingway & Ranson, 2000). However, the molec-
ular drivers of metabolic resistance have been more difficult to 
decipher due to the greater complexity of this mechanism with 
several genes involved and various molecular processes po-
tentially implicated. Nevertheless, progress has been made re-
cently in elucidating the molecular basis of metabolic resistance 
in malaria vectors. For example, amino acid changes associated 
with the increased metabolic activity of detoxification genes 
have been detected notably in the GSTe2 gene, with L119F de-
tected in A. funestus (Riveron et al., 2014) and I114T in A. gambiae 
(Mitchell et al., 2012). The L119F-GSTe2 was confirmed to confer 
cross-resistance to pyrethroids and DDT (dichlorodiphenyltrichlo-
roethane) (Riveron et al., 2014). An allelic variation of detoxifica-
tion genes has also been shown to confer insecticide resistance 
as described in the case of the P450 genes CYP6P9a and CYP6P9b 
(Ibrahim et al., 2015) and for GSTe2 in the dengue vector Aedes ae-
gypti (Lumjuan et al., 2011). Recently, causative mutations located 
in the cis-regulatory region of key P450 genes were shown to drive 
over-expression of the P450s CYP6P9a (Weedall et al., 2019) and 
CYP6P9b (Mugenzi et al., 2019) in A. funestus. Moreover, evidence 
that copy number variation of detoxification genes was also play-
ing a role in the observed insecticide resistance in mosquitoes 
was shown in the A. gambiae and A. coluzzii (Lucas et al., 2019). 
Additionally, key transcription binding factors, notably Maf-S/
CncC, have been associated with insecticide resistance in major 
malaria vectors. In A. funestus, a major structural variation (SV) in 
the shape of a 6.5-kb insertion was reported in pyrethroid resis-
tance mosquitoes in the intergenic regions of two P450s (CYP6P9a 
and CYP6P9b) (Weedall et al., 2019), raising the prospect that such 
structural variation could also be an key factor driving metabolic 
resistance in mosquitoes. Establishing the potential role of such 
SVs could help to elucidate the molecular basis of resistance and 
also design robust diagnostic tools to detect and track resistance 
in the field for current and future insecticides.
Therefore, to elucidate the potential role of structural variation 
in pyrethroid resistance, we assess the contribution of the 6.5-kb 
insertion in the vicinity of key P450 resistance genes in resistant 
A. funestus mosquitoes. We demonstrate using functional assays and 
genotype/phenotype studies that the 6.5-kb insertion has a key role 
in the over-expression of P450 resistance genes. We designed a PCR 
(polymerase chain reaction)-based diagnostic that allows us to track 
this SV-based resistance and use it to show that this 6.5-kb insertion 
acts as an enhancer significantly contributing to increase pyrethroid 
resistance and to exacerbate the loss of efficacy of long-lasting in-
secticidal nets against malaria vectors.
2  | MATERIAL S AND METHODS
2.1 | Mosquito laboratory strains and field 
populations
Two Anopheles funestus laboratory colonies of FUMOZ-R and FANG, 
which are resistant and susceptible to pyrethroids respectively, were 
used (Hunt et al., 2005). FUMOZ-R originates from Mozambique 
while FANG is from Angola. Available DNA samples from previous 
studies including F8 generation samples derived from the reciprocal 
crosses between the FUMOZ and FANG (Wondji et al., 2009) were 
used. Additionally, field-collected mosquito samples from several 
countries across Africa were also used for genotyping, including 
Democratic Republic of Congo (DRC) (2015) and Cameroon (2016) 
for central Africa, Ghana (2014) for West Africa, Uganda (2014) and 
Tanzania (2015) for East Africa, and Zambia (2015), Malawi (2014) 
and Mozambique (2016) for Southern Africa. These field samples 
were collected indoor using electric aspirators as previously de-
scribed (Weedall et al., 2019).
Furthermore, reciprocal crosses between FUMOZ-R and 
FANG were carried out to assess the correlation between the 
6.5-kb SV and the pyrethroid resistance phenotype. The genetic 
crosses also reduced the bias due to the difference in background. 
To perform these crosses, 30 FUMOZ-R males and 30 virgin FANG 
females were allowed to mate and the eggs reared to the next 
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generation, and adults of the following generations intercrossed 
up to F6.
2.2 | Screening of the 6.5-kb SV from whole-
genome sequences from different regions of Africa
The sequencing data obtained by pooling DNA from several mosqui-
toes (Pool-Seq) for several populations of A. funestus (Malawi, Ghana, 
Benin, Cameroon, Uganda, Mozambique, DRC Kinshasa and DRC 
Mikalayi) were analysed to confirm the presence and distribution 
of the 6.5-kb insert Africa-wide following the protocol described by 
Weedall et al. (2020). Initial processing and quality assessment of the 
sequence data was performed as described by Weedall et al. (2019). 
Pool-Seq R1/R2 read pairs and R0 reads were aligned to the refer-
ence sequence using bowtie2 (Langmead & Salzberg, 2012). Variant 
calling was carried out using snver version 0.5.3, with default pa-
rameters (Wei et al., 2011). Single nucleotide polymorphisms (SNPs) 
were filtered to remove those with total coverage depth <10 and 
more than the 95th percentile of the distribution of the mean depth 
across SNPs for each sample, as the allele frequency estimates could 
be inaccurate due to low coverage or misaligned paralogous se-
quence, respectively.
2.3 | Comparative amplification and 
sequencing of the CYP6P9a and CYP6P9b intergenic 
region between FUMOZ-R and FANG
The Livak protocol (Livak, 1984) was used to extract DNA from 
mosquito samples. The extracted DNA was quantified using a 
NanoDrop lite spectrophotometer (Thermo Scientific). The inter-
genic region between CYP6P9a and CYP6P9b was amplified for both 
the pyrethroid-resistant laboratory strain FUMOZ-R and the FANG 
pyrethroid-susceptible laboratory strain. The intergenic region for 
FANG was amplified using primers 6P9a5F and GAP3R (Appendix 
S1) using 1 U KAPA Taq polymerase (Kapa Biosystems) in 1× buffer 
A, 25 mm MgCl2, 25 mm dNTPs and 10 mm of each primer. This was 
used to constitute a 15-µl PCR mix using the following conditions: 
initial denaturation step of 3 min at 95°C, followed by 35 cycles 
of 30 s at 94°C, 2 min at 58°C and 60 s at 72°C, with 10 min at 
72°C for final extension. The FUMOZ-R was amplified with primers 
GAP1F and GAP3R (S1) using Phusion high-fidelity DNA polymer-
ase (Thermos Scientific). The mix was made using GC buffer, 3% 
DMSO (dimthyl sulphoxide), 25 mm dNTPs, 10 mm of each primer 
and DNA from FUMOZ as template. The PCR conditions were as 
follows: 10 min predenaturation at 98°C, 35 cycles of 10 s dena-
turation at 98°C, 30 s annealing at 62°C, 4 min extension at 72°C 
and a final extension at 72°C for 10 min. The PCR product was run 
on a 1% gel and visualized on an ENDURO GDS (Labnet) UV transil-
luminator. The PCR product was gel purified and ligated to PJET1.2 
blunt end vector and sequenced. Sequencing data were analysed 
with bioedit (Hall, 1999).
2.4 | Assessment of the transcriptional 
activity of the 6.5-kb SV using luciferase assay
2.4.1 | Cloning of the intergenic CYP6P9a-CYP6P9b 
for promoter activity assay
The 8.2-kb intergenic region of CYP6P9a and CYP6P9b of the 
FUMOZ-R colony was amplified using primers 6P9bUTR8.2F 
(CGAGCTCGTAAGTAACACACAAAATGGT) and 6P9aUTR8.2R 
(CGGCTAGCCGATTTCGTTCGCCGAATTCCA), as described above 
and DNA from FUMOZ-R as a template. The recombinant plasmid 
was digested with restriction enzymes Sac1 and Nde1 and subcloned 
in pGL3 Basic luciferase vector (Promega).
2.4.2 | Luciferase reporter assay
The transfection and the luciferase assay was done as previously 
described (Weedall et al., 2019) using A. gambiae 4a-2 cell line (MRA-
917 MR4, ATCC). Due to the large difference in size between the 
recombinant promoter constructs, an equimolar amount of each 
construct was used for the transfection. Luciferase assay compared 
the 8.2-kb intergenic region of FUMOZ-R to the 0.8-kb CYP6P9a 
promoter constructs for FUMOZ-R and FANG. Five independent 
transfections were carried out. The 0.8-kb CYP6P9a recombinant 
promoter construct of FUMOZ-R contained the core promoter of 
CYP6P9a before the insertion point. Briefly, 600 ng of each promoter 
construct was transfected using the effectene transfection reagent 
(Qiagen). Two additional plasmids were used, the LRIM promoter 
construct which served as a positive control, and the actin-Renilla 
internal control which is used for normalization. A luminometer (EG 
& G Berthold) was used to measure luciferase activity 2 days after 
transfection.
2.5 | Design of a simple PCR assay to 
detect the 6.5-kb SV and analysis of its association 
with pyrethroid resistance
To allow a simple identification of the samples containing the 6.5-
kb insertion, a PCR was designed to discriminate between mos-
quitoes with the 8.2-kb (FUMOZ-R) and 1.-7kb (FANG) CYP6P9a 
and CYP6P9b intergenic region. Briefly, three primers were de-
signed: two (FG_5F: CTTCACGTCAAAGTCCGTAT and FG_3R: 
TTTCGGAAAACATCCTCAA) at regions flanking the insertion 
point and a third primer (FZ_INS5R: ATATGCCACGAAGGAAGCAG) 
in the 6.5-kb insertion. One unit of KAPA Taq polymerase (Kapa 
Biosystems) in 1× buffer A, 25 mm MgCl2, 25 mm dNTPs and 10 mm 
of each primer was used to constitute a 15-µL PCR mix using the 
following conditions: initial denaturation step of 3 min at 95°C, fol-
lowed by 35 cycles of 30 s at 94°C, 30 s at 58°C and 60 s at 72°C, 
with 10 min at 72°C for final extension. The amplicon was re-
volved on a 1.5% agarose gel stained with Midori Green Advance 
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DNA Stain (Nippon genetics Europe GmbH) and revealed on a UV 
transilluminator.
To assess the ability of the assay to discriminate between mos-
quitoes with the SV and those without, the assay was tried on ge-
nomic DNA extracted from 48 FUMOZ-R and 50 FANG female 
mosquitoes. Next, we used F8 mosquitoes from the FUMOZ-R and 
FANG crossing which had been exposed to permethrin 0.75% at two 
different exposure times (30 and 180 min) using the standard WHO 
bioassay protocol. Mortality was recorded 24 hr after exposure and 
samples were categorized into two groups: highly resistant for those 
alive after 180 min of exposure and highly susceptible for those dead 
after 30 min. The samples were genotyped for the 6.5-kb SV to as-
sess the correlation between the 6.5-kb SV and the insecticide sus-
ceptibility phenotype.
2.6 | Correlation between the 6.5-kb PCR 
assay and the CYP6P9a/b PCR-RFLP
The efficacy of the newly designed PCR for the 6.5-kb SV was com-
pared by using PCR-RFLP (restriction fragment length polymor-
phism) methods for detecting the CYP6P9a- and CYP6P9b-resistant 
allele to check the association between the 6.5-kb SV and each of 
the P450s and also for the combined effect of these three markers, 
as described previously (Mugenzi et al., 2019; Weedall et al., 2019). 
DNA samples from previous studies were used as test materials to 
compare the three assays.
2.7 | Assessment of the enhancer's effect of the 
6.5-kb SV on the expression of nearby genes using 
qRT-PCR
Structural variants are known to have the propensity to impact the 
expression of nearby genes on the same chromosome. To investi-
gate the potential enhancer's effect of the 6.5-kb on the expres-
sion of CYP6P9a and CYP6P9b, mosquitoes of the F2 generation 
from the FUMOZ-R and FANG crosses were used to generate the 
various genotypes of the 6.5-kb SV. Total RNA was extracted from 
the F2 generation of FUMOZ-R and FANG crosses, which had been 
genotyped using the newly designed 6.5-k SV detection PCR and 
grouped into three sets: homozygous for the 6.5-kb SV (SV+/SV+), 
heterozygous (SV+/SV−) and homozygous without the SV (SV−/
SV−). DNA was extracted from the legs. Briefly, four to six legs 
were pulled from each mosquito and placed in a 1.5-ml tube. Then, 
25 μl of 1× PCR buffer B (Kapa Biosystems) prewarmed at 65°C was 
added and the legs were ground. The tubes were then centrifuged 
at 18,928 g  for 2 min. The samples were then incubated at 95°C 
for 30 min in a thermocycler. The remaining body of the mosquito 
was kept in RNAlater individually. From each group, 30 mosquitoes 
were pooled in sets of 10 females, and RNA was extracted using the 
Arcturus PicoPure RNA Isolation Kit (Life Technologies). cDNA was 
synthesized from each RNA pool using Superscript III (Invitrogen) as 
previously described (Riveron et al., 2015). The expression pattern 
of CYP6P9a and CYP6P9b was assessed by quantitative real-time 
PCR (qRT-PCR) (Agilent MX3005) to assess the correlation between 
the presence of the 6.5-kb SV and the expression pattern of these 
two resistance genes.
2.8 | Assessment of the impact of the 6.5-kb SV 
on the efficacy of bed nets
2.8.1 | WHO cone bioassays
The efficacy of insecticide-treated net against the strains used 
was tested using a cone assay following the WHO protocol 
(WHO, 2013). Mosquitoes from the F6 generation of the FUMOZ-R 
and FANG crosses were tested against two WHO recommended 
LLINs (PermaNet 2.0 and PermaNet 3.0). PermaNet 2.0 nets consist 
of polyester coated with the deltamethrin to a target dose of 55 mg/
m2 (±25%) while PermaNet 3.0 has a higher dose of deltamethrin 
of 85 mg/m2 (±25%) and piperonyl butoxide (PBO), a synergist in-
corporated with deltamethrin in the polyethylene roof (Vestergaard, 
Frandsen). Briefly, five replicates of 10 F6 females (2–5 days old) 
were placed in plastic cones attached to 30 × 30-cm pieces of nets 
PermaNet 2.0, PermaNet 3.0 (side) and PermaNet 3.0 (roof), and an 
insecticide-free net as a control. After 3 min of exposure, the mos-
quitoes were transferred in holding paper cups and provided with 
cotton soaked in a 10% sugar solution. Mortality was recorded 24 hr 
after exposure. The bed nets were tested against the susceptible 
Kisumu laboratory strain before using them for the study.
2.8.2 | Experimental hut trials
To assess the association between the 6.5-kb SV and a potential re-
duction in the efficacy of insecticide-treated nets, an experimental 
hut trial was performed in a field station (possessing 12 huts) located 
at Mibellon (6°4′60′′N, 11°30′0′′E), a village in Cameroon located 
in the Adamawa Region (Mayo Banyo division and Bankim Sub-
division). A release recapture experiment was done using F5 and F6 
generations of the FANG/FUMOZ-R crosses where about 50–100 
female mosquitoes were released in each hut at 8:00 p.m. with a 
volunteer sleeping under each net (PermaNet 2.0, PermaNet 3.0 and 
control with no insecticide). All the windows of each hut were closed 
from outside to prevent entry of free flying mosquitoes. The 45° 
oblique shape of the window openings also does not allow mosqui-
toes to escape, in addition to the windows being completely closed 
from outside. Both alive and dead, blood-fed and unfed mosquitoes 
were collected in the morning. This involved three treatments: the 
first was untreated polyethylene net, the second PermaNet 2.0 
(impregnated with deltamethrin), and the last PermaNet 3.0 (im-
pregnated with PBO and deltamethrin). Six holes of 4 × 4 cm were 
made on each net following WHO guidelines to simulate a worn net. 
Volunteers were recruited from the village to sleep under the nets 
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and collect mosquitoes in the morning. A consent form was obtained 
from each of the volunteers before participating in the study and 
participants received chemoprophylaxis during the trial. This study 
was approved by the National Ethics Committee of the Ministry of 
Public Health in Cameroon. Mosquitoes were collected in the morn-
ing by each volunteer using tubes. Mosquitoes were collected and 
carefully grouped according to their location in the hut; that is, if in 
the main room (the walls, floor and the hut ceiling), inside of each net 
and the exit traps (veranda). The blood feeding and mortality status 
of the mosquitoes collected, such as alive/blood-fed, dead/blood-
fed, alive/unfed and dead/unfed, were noted.
2.9 | Statistical analysis
Statistical analysis was performed in GraphPad prism 7.05 and alpha 
values for significance were taken at p < .05, with all confidence in-
tervals (CI) at 95%. Student's t-test was used to compare the means 
of data obtained for the luciferase assay and qPCR to determine 
the level of significance. Fisher's exact test was used to determine 
whether any difference in proportion observed for the genotype 
contingency tables is significant and odds ratio was used to quantify 
the strength of association between the genotype and mortality/
blood-feeding status for the data obtained from the cone assay and 
experimental huts.
3  | RESULTS
3.1 | Delimiting the insertion in laboratory colonies 
and identifying its presence in different geographical 
locations in Africa
By aligning the intergenic region between CYP6P9a and CYP6P9b 
for FUMOZ and FANG, the insertion point was identified at 851 bp 
from the stop codon of CYP6P9b and 840 bp from the start codon 
of CYP6P9a. To determine the geographical extent of the 6.5 kb 
SV across African populations of Anopheles funestus, pooled-tem-
plate whole-genome sequencing alignments to the 120 kb rp1 BAC 
from several locations (Malawi, Ghana, Benin, Cameroon, Uganda, 
F I G U R E  1   Detection of the 6.5-kb intergenic insertion between CYP6P9a and CYP6P9b in Anopheles funestus mosquitoes. (a) Screenshot 
from the integrative genomics viewer (IGV), showing the coverage depth and aligned reads for the pyrethroid-resistant FUMOZ-R strain 
(upper) and the fully susceptible FANG (lower) using the pooled template whole genome sequence alignments (Pool-seq). The coverage 
depth plots show deeper coverage in this region in FUMOZ-R but not in FANG. The FANG alignment contains read pairs with unusually long 
insert sizes, indicated in red in the lower panel (thick lines represent reads, read pairs are linked by thin lines). (b) IGV screenshot showing 
an increase coverage depth of reads between CYP6P9a and CYP6P9b in FUMOZ-R with a loss of polymorphism (grey) compared to the 
susceptible FANG strain using Pool-seq data. The same contrast is observed between the 2002 sample from Mozambique before LLIN 
scale up (MOZ-2002) (high diversity and low coverage of read depth) with the 2016 sample (MOZ-2016) where a greater coverage depth is 
observed at the intergenic region corresponding to the insertion of the 6.5-kb fragment. (c) Schematic representation of the 6.5-kb insertion 
in FUMOZ-R in comparison to FANG
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Mozambique, DRC Kinshasa and DRC Mikalayi) across the range 
of A. funestus were inspected. This rp1 BAC spans the cytochrome 
P450 cluster where both CYP6P9a and CYP6P9b are located (Wondji 
et al., 2009). Figure 1 shows alignments for FUMOZ-R and FANG, 
which show both anomalous features. Figure S1 shows the puta-
tive left and right ends of the insertion, defined by the presence of 
“clipped” reads, where the alignment software aligns a part of the read 
to the reference and “clips” off part of the read that does not align. 
The FUMOZ-R alignment contains reads that are left-clipped (the left-
most part of the read, as aligned to the reference, is clipped irrespec-
tive of the read's orientation: so the 5′ end of a read aligned to the 
positive strand and the 3′ end of a read aligned to the negative strand) 
between BAC sequence positions 37,409 and 37,410 (37,410 being 
the leftmost base included in the insertion). It also contains reads that 
are right-clipped between positions 43,954 and 43,955. This defines 
a region of 6,545 bp. The presence of only left-clipped reads on the 
left of the region and right-clipped reads on the right of the region 
indicates two things in FUMOZ-R: (a) that the “insertion” form of the 
indel is fixed in the FUMOZ-R sample (there is no evidence for the 
presence of the “deletion” form), and (b) that the inserted sequence 
is homologous to part of a larger sequence found elsewhere in the 
genome (indicated by the “clipped” parts of the reads). In the suscep-
tible FANG, the situation is more complicated. At the left end of the 
insertion, there are reads left-clipped between positions 37,409 and 
37,410 (as for FUMOZ-R) but also some reads right-clipped slightly 
further left, between positions 37,404 and 37,405. At the right end of 
the insertion, there are reads right-clipped between positions 43,954 
and 43,955 (as for FUMOZ-R) but also some reads left-clipped be-
tween the same positions. Also, further to the right there are some 
reads right-clipped between positions 44,053 and 44,054 and some 
left-clipped between positions 44,070 and 44,071. Detailed inspec-
tion of the clipped reads showed that the reads right-clipped at 
37,404/37,405 and left-clipped at 43,954/43,955 indicate the “dele-
tion” form of the indel, as the clipped parts of the reads from the left 
and right end of the insertion overlap each other (but also contain a 
short length of DNA that does not match FUMOZ-R). The clipping 
at 44,053/44,054 and 44,070/44,071 is due to a region of 35 bp 
in FANG (TAATACCGGGAGATACATGGAGCTCGTGTAAAAGA) that 
does not align with the FUMOZ reference (ATATGTCGGAGGTTTAT) 
at the same location. Overall, FANG shows evidence of the “deletion” 
form of the indel in addition to the presence of the large homologous 
sequence elsewhere in the genome (Figure 1a). This makes simple in-
spection of the alignment misleading, as rather than a loss of coverage 
across the 6.5-kb indel, coverage is seen due to reads originating from 
sequence elsewhere in the genome. This is illustrated in Figure S1A. 
Overall, FUMOZ-R exhibits an increased coverage depth of reads 
between CYP6P9a and CYP6P9b with a loss of polymorphism com-
pared to the susceptible FANG strain (Figure 1b). The same contrast 
is observed between the 2002 sample from Mozambique before the 
scale-up of LLIN (2002) with low coverage of read depth in contrast to 
the 2016 sample showing a greater coverage depth at the intergenic 
region corresponding to the insertion of the 6.5-kb fragment.
The results also indicate that the 6.5-kb insertion between 
CYP6P9a and CYP6P9b was present only in the southern African 
population of Malawi, where it was nearly fixed (only a single read 
in Malawi supported the deletion haplotype) (Table S1). However, 
populations from other parts of Africa showed no evidence of the 
insertion haplotype.
Evidence that the insertion probably existed (albeit at low fre-
quency) in the early 2000s comes from its presence in the FUMOZ-R 
colony, which was colonized from the field in Mozambique in 2000, 
and subsequently selected for insecticide resistance, which appears 
to have fixed the insertion haplotype in the colony. However, one 
could not also rule out a de novo occurrence of this SV in FUMOZ-R 
during the selection process.
3.1.1 | Investigating the genomic origin of the 6.5-
kb insertion
To identify the genomic origin of the inserted 6.5-kb sequence, 
its entire sequence was used to search the A. funestus FUMOZ 
AfunF3 reference genome assembly using blastn implemented in the 
VectorBase web resource. The results indicated that the sequence 
occurred at another different location in the genome, on scaffold 
CM012071.1 (Figure S2A). That location is between 8,296,288 
and 8,555,956, ~260 kb away from the CYP6 cluster on the same 
scaffold (therefore, on the same chromosome 2). Both loci are on 
chromosome 2R in the same genomic region as the P450s cluster 
rp1 quantitative trait locus (Wondji et al., 2009) which confers high 
pyrethroid resistance and shown to have undergone a major selec-
tive sweep. In addition, short (100 bp) sequences from the left and 
right ends of the insertion were used to conduct blastn searches 
of AfunF3 and confirmed the results obtained with the full-length 
insertion sequence. Finally, clipped sequences from immediately 
to the left and right of the insertion were used to conduct blastn 
searches of AfunF3. The results (matches only adjacent to the 
CM012071.1:8,296,288–8,555,956 region) confirmed that the 
“parent” sequence of the insertion between CYP6P9a and CYP6P9b 
came from CM012071.1:8,296,288–8,555,956. This putative 
genomic “parent” sequence of the insert contains no annotated pro-
tein-coding genes but there is a large assembly gap in the region. The 
orthologous region in the Anopheles gambiae genome is also on chro-
mosome arm 2R (Figure S2B). The protein-coding genes flanking the 
insertion sequence, AFUN008344 and AFUN008346, are ortholo-
gous to AGAP002842 and AGAP002845, respectively. A. gambiae 
also has no annotated protein-coding genes between AGAP002842 
and AGAP002845, suggesting that A. funestus may not have also. 
Two micro-RNAs annotated in both species are outside of the inser-
tion sequence. Despite the lack of annotated genes, the region is 
transcribed as supported by FUMOZ-R RNA sequencing showing a 
large transcribed region (Figure S2C), with some evidence of splicing, 
covering the two annotated micro-RNAs. Whether this transcript is 
processed to form mature micro-RNAs is not known.
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3.2 | Comparative promoter analysis of the 
CYP6P9a–CYP6P9b intergenic region
The location of the 6.5-kb insertion in the intergenic region between 
CYP6P9a and CYP6P9b (Figure 1c) indicated that this insertion could 
impact the regulation of these genes. This is strongly supported by 
their high expression in FUMOZ-R and Southern Africa mosquito 
populations. To verify this hypothesis, the full-length intergenic frag-
ment (8.2 kb) was successfully PCR-amplified and cloned (Figure S2D) 
and used for a luciferase reporter assay (Pgl3 FZ6P9a8.2) compara-
tively with three other construct vectors without the 6.5-kb SV (Pgl3 
FZ6P9a0.8, Pgl3 FG6P9a0.8 and Pgl3 LRIM). These constructs were 
transfected alongside Renilla luciferase plasmid in the A. gambiae 
4a-2 cell line. The samples were lysed and luciferase activity was 
measured and normalized against Renilla activity. The luciferase 
activity of the construct with the 6.5-kb SV from FUMOZ-R, Pgl3 
FZ6P9a8.2, was five-fold significantly higher (p = .00012) than that 
of the same strain without it, FZ6P9a0.8, and 17.5-fold higher than 
the FANG fragment, Pgl3 FG6P9a0.8 (p < .0001). This result implies 
that this insertion probably contains cis-regulatory elements act-
ing as gene regulation enhancers and driving the high expression of 
CYP6P9a and CYP6P9b observed (Figure 2a).
3.3 | A simple PCR assay to detect the 6.5-kb 
SV and associated pyrethroid resistance
The 8.2-kb (SV+) and 1.7 kb (SV−) intergenic regions were used to 
design a simple PCR assay capable of detecting the 6.5-kb structural 
variant. The PCR comprised three primers, two in the flanking region 
and one in the 6.5-kb region (Figure 2b). The presence of the SV is 
shown by the amplification of a fragment of 596-bp (SV+) whereas the 
F I G U R E  2   Functional characterization of the 6.5-kb SV and design of a PCR diagnostic assay. (a) Comparative Luciferase reporter assay 
(normalized to renilla fluorescence) of various intergenic fragments between CYP6P9a and CYP6P9b. Pgl3 FZ6P9a8.2 is the fragment for 
the full 8.2 intergenic region containing the 6.5-kb insertion showing a highly elevated activity compared to others. Pgl3 FZ6P9a0.8 is the 
800 bp region upstream of CYP6P9a containing cis-regulatory elements used to design the PCR assay for CYP6P9a (Weedall et al., 2019) 
whereas Pgl3 FG6P9a0.8 is the FANG version. Bars represent the mean ± SD of five independent transfections of three replicates (n = 5). (b) 
Schematic representation of the design of the PCR assay to detect the 6.5-kb insertion using three primers, two located immediately outside 
of the SV (FG_5′ and FG_3′; size of 266 bp if no SV) and one located within the 6.5-kb SV, allowing us to detect its presence (expected band 
596 bp). (c) Agarose gel showing the three genotypes indicating the presence (+) or absence (−) of the insertion using F8 FUMOZ × FANG 
crosses. Ladder: 100 bp, n.c.: negative control. (d) Distribution of the 6.5-kb SV genotypes between susceptible (Dead) and resistant 
(Alive) mosquitoes after WHO bioassays with 0.75% permethrin showing a very strong correlation between the 6.5-kb SV and pyrethroid 
resistance phenotype. (e) Distribution of the combined genotypes of 6.5 kb and that of CYP6P9a after WHO bioassays with 0.75% 
permethrin showing that both genotypes combined to increase pyrethroid resistance. (f) Distribution of the combined triple genotypes of 
6.5 kb besides that of both P450s CYP6P9a and CYP6P9b after WHO bioassays with 0.75% permethrin, showing that the triple genotypes 
combined to further increase pyrethroid resistance
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absence is shown by a band at 266 bp (SV−) (Figure 2c). To assess the 
efficacy of this novel PCR, we genotyped the FANG-S and FUMOZ-R 
strains for the 6.5-kb SV and found that all FUMOZ-R mosquitoes gen-
otyped were homozygous for insertion (SV+/SV+) while all the FANG 
mosquitoes were homozygous without insertion (SV−/SV−).
To assess the association between this 6.5-kb SV and pyrethroid 
resistance in A. funestus, F8 mosquitoes obtained from crossing 
FANG and FUMOZ-R which had been exposed to 0.75% permethrin 
for 180 min to get highly resistant (alive) mosquitoes and 30 min to 
get highly susceptible (dead) mosquitoes were genotyped for this 
SV. Genetic crosses between FANG and FUMOZ-R were used to 
reduce the bias due to the background of the strains. The results 
revealed that those alive after 180 min of exposure were mainly ho-
mozygous (21/45) and heterozygous (22/45) for the 6.5-kb SV. Only 
2/45 alive were lacking the 6.5-kb SV. Genotyping of the 41 highly 
susceptible mosquitoes revealed that 40/41 were homozygous with-
out the 6.5-kb SV and 1/41 heterozygous (Figure 2d). Consequently, 
a strong association was found between permethrin resistance and 
6.5-kb SV genotype with a highly significant odds ratio (OR) when 
comparing the homozygote (SV+/SV+) to the homozygote (SV−/
SV−) (SS) (OR = 2079.4, p < .001, Fischer's exact test). Similarly, a 
significantly higher ability to survive was observed for the hetero-
zygote (SV+/SV−) when compared to the homozygote (SV−/SV−) 
(OR = 600.25, p < .001, Fischer's exact test) (Figure 2d) (Table S2). 
Moreover, analysis of the combined effect of the 6.5-kb SV with the 
two nearby P450s revealed increased survivorship when the 6.5-kb 
SV is combined to either CYP6P9a (Figure 2e: Table S2) or CYP6P9b 
(Table S2) with an even greater chance to survive when a mosquito is 
triple homozygous for the resistant allele at the three loci (Figure 2f; 
Table S2).
3.4 | Enhancer's effect of the 6.5-kb SV on the 
expression of nearby genes
To confirm the potential enhancer role of the 6.5-kb SV on the reg-
ulation of nearby P450 genes, as suggested by the luciferase pro-
moter assay, qRT-PCR was used to compare the expression of the 
nearby CYP6P9a and CYP6P9b P450 genes. Mosquitoes obtained 
from F2 crossing of FUMOZ-R and FANG were pooled into three 
groups based on their genotypes (SV+/SV+, SV+/SV− and SV−/
SV−) for the 6.5-kb SV (Figure 3a,b). The analysis revealed that the 
mosquitoes possessing the 6.5-kb SV (SV+/SV+ and SV+/SV−) had 
a significantly higher expression level for CYP6P9a and CYP6P9b 
as opposed to those without the 6.5-kb SV (SV−/SV−) (Figure 3c). 
The expression level of CYP6P9a for mosquitoes with the SV+/SV+ 
genotype was about 1.7-fold (p = .03) higher than that of SV+/SV− 
genotype and 5.2-fold higher than the homozygote without SV (SV−/
SV−) (p = .005). A similar pattern was observed for CYP6P9b with 
the homozygote SV+/SV+ genotype expressing CYP6P9b about 
two-fold higher than heterozygote mosquitoes (p = .003) and 4-fold 
higher than the homozygote SV−/SV− (p = .001). This suggests a 
strong association between the 6.5-kb SV and increased expression 
of CYP6P9a and CYP6P9b probably as a result of the presence of cis-
regulatory elements in the 6.5kb acting as enhancers.
3.5 | Geographical distribution of 6.5-kb SV 
across Africa
This novel diagnostic PCR was tested on wild-collected A. funestus mos-
quitoes from various African regions to determine the spread of this in-
sertion across the continent. Genotyping of the 6.5-kb SV was successful 
in all the seven countries, revealing that this SV is present in Southern 
Africa mosquito populations but absent from those collected in Central 
and Western Africa (Figure 4a). The frequency of 6.5-kb SV was very high 
in southern Africa ranging from 82% in Zambia (collected in 2015), 92% 
in Malawi (2014), and 100% in Mozambique (2016) (Figure 4b). Tanzania 
(2015) and Eastern Democratic Republic of Congo (2015) presented 
intermediate frequencies (43.94% and 72.2%, respectively). The 6.5-kb 
SV was completely absent in Western (Ghana, 2014), Eastern (Kenya 
[2014], Uganda [2014]), and Central Africa (Cameroon [2016] and DRC-
Kinshasa [2015]). Hence this SV is confined to Southern Africa as with 
the CYP6P9a and CYP9P9b P450-based pyrethroid resistance (Mugenzi 
et al., 2019; Weedall et al., 2019) and contrary to the L119F and A296S 
resistance-to-dieldrin (RDL) mutation, which confers DDT and dieldrin 
resistance respectively (Riveron et al., 2014). Samples from Tanzania and 
DRC-Mikalayi that show segregation of different genotypes were fur-
ther used to assess the potential association between the 6.5-kb SV, 
CYP6P9a and b (Figure 4c; Figure S3A,B). In Tanzania, a greater linkage of 
the three markers was observed with 54.8% (17/31) identical genotypes 
detected while the value was lower in DRC-Mikalayi at 32% (8/25). 
Considering only CYP6P9a and the 6.5-kb SV, 12% (3/25) and 16% 
(5/31) had the same genotype for both markers for DRC-Mikalayi and 
Tanzania respectively. A low genotypic frequency of 8% (2/25) was ob-
tained for samples with the same genotype for CYP6P9b and the 6.5-kb 
SV for DRC-Mikalayi. Concerning CYP6P9a and CYP6P9b, 48% (12/25) 
and 25.81% (8/31) from DRC-Mikalayi and Tanzania respectively had 
the same genotype (Figure 4c).
3.6 | The 6.5-kb SV is associated with reduced bed 
net efficacy
The association between the 6.5-kb SV and bed net efficacy was 
assessed using mosquitoes previously used to validate CYP6P9a 
(Weedall et al., 2019) and CYP6P9b (Mugenzi et al., 2019). Mosquitoes 
from the FUMOZ and FANG crossings were reared to the F6 genera-
tion, which was used for cone assays and to perform a release recap-
ture in experimental huts.
3.6.1 | Cone assays
To validate the ability of the 6.5-kb SV marker to predict the impact 
of resistance on the efficacy of LLINs, we genotyped F6 samples 
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obtained from cone assays with PermaNet 2.0 and PermaNet 3.0 
(side). A mortality rate of 100% was obtained when the Kisumu 
susceptible strain was exposed to these nets. Mortality rates were 
31.1% and 40.7% for PermaNet 2.0 and PermaNet 3.0 respectively 
with no significant difference (p = .380). With PermaNet 2.0, a sig-
nificant difference in the distribution of genotypes of the SV was 
observed between dead and alive mosquitoes (χ2 = 892; p < .0001, 
Chi-square test) (Figure 5a). Comparing the proportion of each SV 
genotype between alive and dead mosquitoes revealed that SV+/
SV+ homozygote mosquitoes were significantly more likely to sur-
vive exposure to PermaNet 2.0 than those completely lacking the 
SV (SV−/SV−) (OR = 1,798.3; CI = 97.6–33,141; p < .0001, Fisher's 
exact test). Heterozygotes were also more able to survive expo-
sure to PermaNet 2.0 than homozygotes lacking the SV (SV−/SV−) 
(OR = 261.5; CI = 15.4–4,447.3; p < .0001, Fisher's exact test). SV+/
SV+ homozygous mosquitoes were also more able to survive than 
heterozygotes (OR = 7.4; CI = 2.5–21.5; p = .0002, Fisher's exact 
test) showing an additive effect of the 6.5-kb SV on the resistance 
phenotype. When comparing at the allelic level, it was observed that 
possessing a single SV+ allele provides a significant ability to survive 
exposure to PermaNet 2.0 compared to the SV− allele (OR = 27.7; 
CI = 12.9–59.0; p < .0001, Fisher's exact test) (Figure 5a; Table S3). 
A similar trend was observed with PermaNet 3.0 (side) (Figure 5a; 
Table S4) whereas we could not assess PermaNet 3.0 (Top) as there 
were no survivors after exposure.
3.6.2 | Experimental hut trial
Different sets of mosquitoes were released over four consecutive 
nights in a release-recapture experiment and used to validate the 
influence of the 6.5-kb SV on bed net efficacy. Mortality rates were 
98.7% for PermaNet 3.0 and 33.3% for PermaNet 2.0 (Weedall 
et al., 2019). To avoid bias due to exophily and feeding status, only 
samples that were unfed and in the room were used. A significant 
difference was observed in the distribution of genotypes of the SV 
among the alive and dead mosquitoes (χ2 = 40.2; p < .0001, Chi-
square test) (Figure 5b,c).Comparison of the proportion of different 
genotypes among the dead and alive mosquitoes revealed that 6.5-
kb SV homozygotes (SV+/SV+) were able to significantly survived 
exposure to PermaNet 2.0 more than those without the 6.5-kb SV 
(SV−SV−) (OR = 27.7; CI: 13.0–59.0; p < .0001, Fisher's exact test; 
Table 1). Mosquitoes heterozygous for the 6.5-kb SV (SV+/SV−) also 
survived exposure to PermaNet 2.0 more than homozygotes without 
the 6.5-kb SV (SS) (OR = 7.5; CI: 3.8–14.8; p < .0001, Fisher's exact 
test). However, the 6.5-kb SV heterozygotes (SV+/SV−) survived less 
than the 6.5-kb SV homozygotes (SV+/SV+) (OR = 3.7; CI = 1.9–7.1; 
p = .0001, Fisher's exact test), suggesting that there is an additive ef-
fect associated with possessing two copies rather than one. This was 
further demonstrated by the ability of mosquitoes having a single 
6.5-kb SV to survive more than those without (Figure 5b). A similar 
trend was observed when the analysis was performed without ex-
cluding exophilic status and blood-fed status (Table S5) as well as for 
PermaNet 3.0 (Figure S4A, Tables S6 and S7).
The distribution of the 6.5-kb SV in blood-fed mosquitoes was 
assessed to determine any association between this SV and the 
ability of mosquitoes to blood-feed in the presence of the bed-
net. A greater number of mosquitoes were able to blood-feed 
with PermaNet 2.0 (14.8%) compared to PermaNet 3.0 (6.8%) 
(Weedall et al., 2019). A significant difference was observed for 
the distribution of the 6.5-kb SV genotypes between blood-fed 
and unfed mosquitoes collected from huts with both PermaNet 
F I G U R E  3   Investigation of the enhancer role of the 6.5-kb SV using comparative gene expression profile of the three SV genotypes on 
CYP6P9a and CYP6P9b. (a) Schematic representation of the three 6.5-kb SV genotypes expected in Anopheles funestus mosquitoes during 
the crossing process. (b) Experimental design of the crossing between the pyrethroid-resistant strain FUMOZ-R (with 100% SV) and the 
fully susceptible FANG (no SV) up to the F3 generation. Expected segregation of genotypes is shown. (c) Differential qRT-PCR expression 
for different insertion genotypes of two cytochrome P450 genes in the immediate vicinity of the 6.5-kb SV. Error bars represent standard 
deviation (n = 3)
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3.0 (χ2 = 18.4; p < .0001) and PermaNet 2.0 (χ2 = 60.2; p < .0001). 
A significant association was observed between the 6.5-kb SV 
genotypes and the ability of mosquitoes to blood-feed when ex-
posed to PermaNet 3.0. Mosquitoes homozygous for the 6.5-kb 
SV (SV+/SV+) were more likely to blood-feed in the presence 
of PermaNet 3.0 than those homozygous without (SV−/SV−) 
(OR = 355.2; CI = 21.4–5,889.4; p < .0001) and heterozygous for 
the 6.5-kb SV (SV+/SV−) (OR = 2.6; CI = 1.3–4.0; p = .00489). 
Mosquitoes heterozygous for the 6.5-kb SV (SV+/SV−) were also 
able to blood-feed more than those without the SV (SV−/SV−) 
(OR = 158.3; CI = 9.6–2,620.0; p = .0004) (Figure 5d; Table 2). 
Analysis of genotype distribution for PermaNet 2.0 gave similar 
trends, but these were not significant apart from SV+/SV− vs. 
SV−/SV− (Figure S4B, Table S8).
3.7 | The 6.5-kb SV combines with CYP6P9a and 
CYP6P9b to further reduce LLIN efficacy
We next assessed the impact of different combinations of geno-
types for the three loci on the efficacy of LLINs. The cone assay 
results revealed increased survivorship when the 6.5-kb SV was 
combined with CYP6P9a for PermaNet 2.0 (Figure S5A; Table S3) 
and PermaNet 3.0 (side) (Figure S5B; Table S4). Similar patterns were 
observed when combined with CYP6P9b (Figure S5C,D; Tables S3 
and S4). Mosquitoes triple homozygous for the resistant allele at the 
three loci exhibited a greater ability to survive than all other geno-
type combinations for both nets (Figure S5E,F; Tables S3 and S4).
Experimental hut trials also showed that triple RR/RR/SV+SV+ 
homozygotes were more likely to survive exposure to PermaNet 
F I G U R E  4   Geographical distribution of the 6.5-kb SV across Africa. (a) Map of Africa showing the genotypic distribution of the 6.5-kb 
SV across the continent which correlated with the CYP6P9a_R and CYP6P9b_R allele distribution. (b) Histogram showing the frequency 
of the SV+ and SV− alleles across Africa, revealing a clear gradient from Mozambique (100% SV+) to West/Central Africa (0% SV+). (c) 
Distribution of the combined genotypes CYP6P9a, CYP6P9b and 6.5kb SV in Tanzania and DRC Mikalayi showing extensive segregation of 
the genotypes to these loci in the field
     |  4405MUGENZI Et al.
2.0 than any other combined genotype (Figure 6a; Table 1). RR/RR/
SV+SV+ survived more than the SS/SS/SV−SV− (OR = 2,505.8; CI: 
141.1–44,486.7; p < .0001), RR/RS/SV+SV− (OR = 31.0; CI = 1.8–
529.3; p = .0177) and RS/RS/SV+SV− mosquitoes (OR = 134.6; CI: 
8.1–2228.4; p = .0006). There was no significant difference between 
the RR/RR/SV+SV+ and RR/RR/SV+SV− genotypes (OR = 1; CI = 
0.02–50.9; p = 1.0) and both had a similar trend in terms of survival 
with the same odds ratio (Figure 6b; Table 1). Hence, there is an ad-
ditive advantage associated with the mosquito combined genotype 
at the three loci which confers a higher level of pyrethroid resistance 
and leading to a greater reduction in bed net efficacy. The impact 
decreased in the order RR/RR/SV+SV+ = RR/RR/SV+SV− > RR/
RS/SV+SV− > RS/RS/SV+SV− > SS/SS/SV−SV−. This additive effect 
was also observed for the PBO-based PermaNet 3.0 net although 
to a lower extent (OR = 423; p < .0001; RRR/RR/SV+/SV+ vs. 
SS/SS/SV−/SV−) (Figure S4C; Tables S6 and S7). Moreover, an in-
creased ability to survive exposure to LLIN was observed even when 
combining genotypes of the 6.5-kb SV only to either of CYP6P9a 
(Figure S6A,B) or CYP6P9b (Figure S7A,B).
In addition to the ability to survive bed net exposure, RR/RR/
SV+SV+ also had a higher ability to blood-feed compared to SS/SS/SV−
SV− (OR = 5.0; CI: 2.7–9.0; p < .0001) and the other combinations in 
the presence of PermaNet 3.0 (Figure 6c,d). This additive effect was also 
observed when combining genotypes of the 6.5-kb SV only to either of 
CYP6P9a (Figure S6C,D) or CYP6P9b (Figure S7C,D). For PermaNet 2.0 
no significant association was observed (Figure S4D; Table S8).
F I G U R E  5   Impact of the 6.5-kb enhancer on the efficacy of insecticide-treated nets using experimental hut trials. (a) Distribution of 
6.5-kb SV genotypes among mosquitoes that survive exposure to PermaNet 2.0 (P2) and PermaNet 3.0 (side) (P3) and those that died 
using cone assays, showing an increased ability to withstand exposure to bed nets when possessing one and two copies of the 6.5-kb SV. 
(b) Distribution of 6.5-kb SV genotypes between dead and alive mosquitoes after exposure to PermaNet 2.0 net in huts, showing that the 
6.5-kb SV significantly allows mosquitoes to survive exposure to this bed net. (c) Correlation between the frequency of 6.5-kb SV alleles 
and ability to survive exposure to PermaNet 2.0 Odds ratio = 3.5; 95% CI: 1.9486–6.2866 and p < .0001. (d) Distribution of the 6.5-kb SV 
genotypes between blood-fed and unfed mosquitoes after exposure to the PBO-based net PermaNet 3.0 in huts, showing that the SV+ 
allele increases the ability to take a blood meal even for PBO-based nets
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3.8 | Scale-up of bed nets is associated with combined 
selection of 6.5-kb SV, CYP6P9a and CYP6P9b
We assessed how these three loci are being selected for in the field 
using mosquito samples collected in 2002 and 2016 in southern 
Africa (Mozambique). The results revealed that the genotypes in the 
2002 samples were skewed towards SS/SS/SS (92.59%) while those 
collected in 2016 were RR/RR/RR (100%) (Figure 6e; and Figure S8). 
This observed selection of RR/RR/RR marches with the scale-up of 
bed nets with samples with the RR/RR/RR genotype being com-
pletely absent before the introduction of bed nets and its fixation 
after many years of bed nets usage. Hence scale-up of vector control 
interventions may have played a major role in the selection of the 
combined resistant genotype at the three loci.
4  | DISCUSSION
This study investigated the role that SVs in cis-regulatory regions 
play in cytochrome P450-mediated metabolic resistance to pyre-
throids in mosquitoes by focusing on a 6.5-kb intergenic insertion 
between two duplicated P450s in the malaria vector Anopheles fu-
nestus. This work showed that the 6.5-kb SV acts an enhancer for 
nearby duplicated P450 genes CYP6P9a and CYP6P9b, leading to 
their increased overexpression. This 6.5-kb SV is strongly associated 
with an aggravation of pyrethroid resistance, which reduces the ef-
ficacy of pyrethroid-only nets but also to some extent that of PBO 
nets. This study improves our understanding of the molecular pro-
cesses that drive P450-based resistance to insecticides in mosqui-
toes while providing an additional marker for monitoring pyrethroid 
resistance in wild A. funestus populations.
4.1 | The 6.5kb SV acts as an enhancer for the up-
regulation of duplicated P450 genes
The whole-genome Pool-seq confirmation of the 6.5-kb insertion 
in field populations of A. funestus supported the previous report 
in the laboratory pyrethroid-resistant FUMOZ-R strain (Weedall 
et al., 2019). The present study has shown that this insertion acts as 
an enhancer to the over-expression of both duplicated P450 genes 
CYP6P9a and CYP6P9b, which are key pyrethroid resistance genes in 
TA B L E  1   Correlation between genotypes of the 6.5-kb SV and 






interval (CI) p value
6.5 SV
SV+/SV+ vs. SV−/SV− 27.7 13.0–59.0 <.0001
SV+/SV+ vs. SV+/SV− 3.7 1.9–7.1 .0001
SV+/SV− vs. SV−/SV− 7.5 3.8–14.8 <.0001



































TA B L E  2   Correlation between genotypes of the 6.5-kb SV 






interval (CI) p value
6.5 SV
SV+/SV+ vs. SV−/SV− 355.2 21.4–5,889.4 <.0001
SV+/SV+ vs. SV+/SV− 2.6 1.3–4.0 .0048
SV+/SV− vs. SV−/SV− 158.3 9.6–2,620.0 .0004
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FUMOZ-R (Amenya et al., 2008; Wondji et al., 2009) and in south-
ern Africa (Riveron et al., 2013; Weedall et al., 2019). The first line 
of evidence that the 6.5-kb insertion serves as an enhancer was 
provided by the comparative promoter assays performed between 
the promoter with the 6.5-kb SV and the core promoter region of 
CYP6P9a. The greater promoter activity observed in the presence 
of the SV than in the absence shows that this insertion increases 
the over-expression of these P450 genes. This is further supported 
by the previous report that the 6.5-kb SV is highly enriched with 
regulatory elements, including several transcription factor binding 
sites as well as several TATA (35), CCAAT (12) and GC (11) sequences. 
Furthermore, the presence of 51 sites for the Cap n Collar C (CnCC) 
and the Muscle aponeurosis fibromatosis (Maf) transcription fac-
tor sites, which are known xenobiotic sensors in insects (Ingham 
et al., 2017; Weedall et al., 2019), supports the role probably played 
by this insertion in enhancing the regulation of neighbouring genes. 
Analysis of the composition of the 6.5-kb insertion provides good 
insight into the architectural characteristics of enhancers in mos-
quitoes and is similar to that of mammalians, which have also been 
shown to include the multiple transcription factor binding sites as 
well as transcriptionally activating and repressing domains in the 
same enhancer (Dickel et al., 2013).
Second, at the transcriptional level, the relative expression of 
CYP6P9a and CYP96P9b were shown to correlate with the 6.5-kb SV 
genotypes. The presence of this SV is strongly associated with in-
creased expression of these two genes (SV+/SV+ > SV+/SV− > SV−/
SV−), which are located upstream and downstream of this SV. It is 
well documented that insertions by introducing novel cis-acting el-
ements into the regulatory regions can either alter the expression 
of a gene or disrupt it (Chung et al., 2007). The fact that this 6.5-
kb SV is enhancing the expression of two genes is in line with what 
is already known about enhancers that can regulate genes in the 
cis- position either upstream (e.g., CYP6P9a) or downstream (e.g., 
CYP6P9b) or even in an intron (Pennacchio et al., 2013). The fact that 
the presence of the 6.5-kb SV impacts the two genes is also in line 
with previous reports stating that enhancers can regulate the ex-
pression of multiple genes (Pennacchio et al., 2013). It will be good 
to establish whether this 6.5-kb SV regulates the expression of other 
F I G U R E  6   The 6.5-kb SV combines with both CYP6P9a_R and CYP6P9b_R P450 alleles to further reduce the efficacy of insecticide-
treated nets. (a) Distribution of combined genotypes for CYP6P9a, CYP6P9b and the 6.5-kb SV showing that the three markers combine 
to increase the chances of being alive in the presence of PermaNet 2.0. (b) Ability to survive exposure to PermaNet 2.0 for the various 
combined genotypes for the 6.5-kb SV, CYP6P9a and CYP6P9b. *p < .05, **p < .01, ***p < .001. (c) Distribution of the combined genotypes 
for the 6.5-kb SV, CYP6P9a and CYP6P9b in mosquitoes collected after exposure to PermaNet 3.0 in huts showing that the three loci 
combine to increase blood feeding ability. (d) The triple RR/RR/SV+SV+ homozygous mosquitoes for the 6.5-kb SV, CYP6P9a and CYP6P9b 
exhibit a greater blood feeding ability than other genotypes. (e) Impact of bed net scale-up in Mozambique on selection of the 6.5-kb SV, 
CYP6P9a and CYP6P9b genotypes with no triple homozygote genotype before (Pre Moz) and 100% after (Post Moz) scale-up of bed nets 
[Colour figure can be viewed at wileyonlinelibrary.com]
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genes besides CYP6P9a/b, notably on the cluster of P450s in this rp1 
resistance locus (Wondji et al., 2009).
Third, the geographical distribution of the 6.5-kb SV tightly cor-
related with the high over-expression of CYP6P9a and CYP6P9b in 
the FUMOZ-R strain and across southern African countries (Riveron 
et al., 2013; Weedall et al., 2019) but a low expression elsewhere 
in Africa where this SV is absent such as in Central, East and West 
Africa (Riveron et al., 2017). This observation further supports 
that the 6.5-kb SV is driving the up-regulation of both genes. This 
is similar to what was reported in Drosophila melanogaster where 
over-expression of the cytochrome P450 gene Cyp6g1, conferring 
DDT resistance, correlated with the insertion of a long terminal re-
peat (LTR) of an Accord retrotransposon in the regulatory region 
of this gene (Catania et al., 2004; Daborn et al., 2002). However, 
contrary to other insertion elements linked to over-expression 
identified so far, this 6.5-kb insertion does not contain a transpos-
able element but mainly putative cis-regulatory elements (Weedall 
et al., 2019). Nardini et al. (2019) identified transcriptional enhancers 
in Anopheles coluzzii proximal to genes relevant to insecticide resis-
tance (Acetylcholinesterase 1 [ACE1, AGAP001356], GABA-gated 
chloride channel subunit [Rdl, AGAP006028]) but not in the cyto-
chrome P450 cluster. Future studies can focus on identifying en-
hancers in the vicinity of genes associated with metabolic resistance 
in other species such as A. gambiae and Aedes.
4.2 | Role of the 6.5-kb SV and aggravation of 
pyrethroid resistance
The design of a simple PCR diagnostic assay to genotype the 6.5-
kb SV has allowed us to establish its contribution to the resistance 
phenotype. First, it has been shown that the 6.5-kb SV segregates 
independently from CYP6P9a and CYP6P9b and thus that it is an ad-
ditional genetic factor driving pyrethroid resistance beside the allelic 
variation of both genes previously reported (Ibrahim et al., 2015). The 
independent segregation of the 6.5-kb SV is also shown by the in-
creased pyrethroid resistance that it confers when using either WHO 
bioassays or cone assays. The fixation of this SV, besides the resistant 
alleles of CYP6P9a and CYP6P9b, could explain the resistance escala-
tion currently reported in several mosquito populations of A. funestus 
such as in Mozambique (Riveron et al., 2019) and Malawi (Riveron 
et al., 2015) and which is reducing the efficacy of insecticide-treated 
nets (Riveron et al., 2019). The near fixation of the 6.5-kb SV seen in 
southern Mozambique after bed nets (2016) but its absence before 
bed net scale up (2002) is an indication that this SV is strongly associ-
ated with resistance exacerbation. Fixation of the 6.5-kb SV in highly 
resistant wild populations also suggests that escalation of pyrethroid 
resistance could be driven, among others, by an increased metabolic 
resistance through genetic elements such as enhancers.
The strong association observed between this SV and pyre-
throid resistance either with WHO bioassays or with cone assays 
shows that this SV can be used as a resistance marker for monitoring 
pyrethroid resistance. This is in addition to the CYP6P9a (Weedall 
et al., 2019) and CYP6P9b (Mugenzi et al., 2019) markers previously 
identified in the promoters of these genes. This novel assay is even 
simpler than the PCR-RFLPs previously designed for CYP6P9a and 
CYP6P9b as it does not require restriction enzymes. There could be 
other undetected genetic variations that are also associated with py-
rethroid resistance but contributing at different levels.
Detection of this 6.5-kb enhancer in the cis-regulatory region of 
major resistance genes further supports that genetic variations in 
this region play a major role in driving metabolic resistance, as seen 
for several resistance genes including the P450 CYP9M10 in Culex 
quinquefasciatus (Wilding et al., 2012), GSTe2 in A. funestus (Mugenzi 
et al submitted) and CYP6G1 in Drosophila (Daborn et al., 2002). 
Therefore, the cis-regulatory region of major metabolic resistance 
genes should be thoroughly investigated to identify additional mark-
ers to design simple DNA-based assays to detect such resistance in 
mosquitoes.
4.3 | Geographical distribution confirms the 
restriction of gene flow in A. funestus
The geographical distribution of the 6.5-kb SV across Africa mir-
rors closely that of the resistance alleles of both CYP6P9a and 
CYP6P9b P450s (Mugenzi et al., 2019; Weedall et al., 2019) with 
the highest frequency observed in southern Mozambique (100%) 
up to eastern DRC (72.2%). It also correlates with the Africa-
wide distribution of the N485 Ace-1 carbamate resistance allele 
in this species (Ibrahim et al., 2016), supporting the existence of 
an insecticide resistance front in southern Africa which signifi-
cantly differs from other regions. The south/north clinal increase 
of frequency in the spread of this SV supports that this resist-
ance probably originated in southern Mozambique and gradually 
migrated northwards in combination with local selection forces. 
The absence of the 6.5-kb SV in other regions of African is in line 
with barriers to gene flow between populations in this species 
across the continent with southern African populations being con-
sistently differentiated from other regions (Barnes, et al., 2017; 
Barnes, et al., 2017; Michel et al., 2005). Restriction of the 6.5-kb 
SV to southern Africa can be explained by the presence of dif-
ferent selective pressures across Africa, as recently shown by an 
Africa-wide study revealing that different regions exhibit differ-
ent signatures of selective sweep (Weedall et al., 2020). These 
regional differences could be explained by the fact that local 
forces driving the development of insecticide resistance may play 
a greater role than the trans-regional spread of resistance genes 
due to barriers to gene flow (Weedall et al., 2020). This can lead 
to different resistance mechanisms in other parts of Africa with 
different genes associated with insecticide resistance. In contrast, 
the 6.5-kb SV distribution is opposite to that of other markers in 
this species, notably the L119F-GSTe2 conferring DDT/pyrethroid 
resistance (Riveron et al., 2014) and the A296S-RDL dieldrin re-
sistance marker (Wondji et al., 2011). Because the 6.5-kb SV allele 
was completely absent in 2002 before the scale up of LLINs while 
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both CYP6P9a and CYP6P9b were already detectable although at 
low frequency (10.9% and 5.2%), it is likely that this SV was se-
lected later as the resistance level increased due to greater selec-
tion pressure. Analysis of larger temporal samples will further help 
to track the selection of this SV.
Analysis of the distribution of the 6.5-kb SV and that of 
CYP6P9a and CYP6P9b in natural populations revealed that alleles 
at these markers do segregate independently in the field, as also 
seen in the hybrid strain FUMOZ-R/FANG at F4 where most of the 
genotypic combinations were observed. This suggests that regard-
less of the proximity of the three loci (a total span of 12 kb), they 
are not physically linked. The higher linkage frequency observed 
in Mozambique and Tanzania may be due to stronger insecticide 
selection applied against these populations as a consequence of 
the scale-up of vector control interventions (Barnes, et al., 2017). 
To determine which gene between CYP6P9a and CYP6P9b is more 
closely linked to the 6.5-kb SV, the percentage linkage for CYP6P9a 
and the 6.5-kb SV was compared with that for CYP6P9b and the 6.-
5kb SV in DRC-Mikalayi and Tanzania. For DRC-Mikalayi, CYP6P9a 
and the 6.5-kb SV had more identical genotypes (12%) than 
for CYP6P9b and the 6.5-kb SV (8%), whereas in Tanzania, only 
CYP6P9a and the 6.5-kb SV were identical genotypes (16%) iden-
tified and none for CYP6P9b and the 6.5-kb SV (0%). Hence, this 
SV—although impacting both genes as shown by comparative qRT-
PCR—appears to have a greater linkage to CYP6P9a. This could also 
support a higher fold-change observed for CYP6P9a in the field in 
southern Africa (Barnes, et al., 2017; Riveron et al., 2013; Weedall 
et al., 2019). This could be because the 6.5-kb SV is located up-
stream of the 5′ untranslated region (UTR) of CYP6P9a but down-
stream of the 3′ UTR of CYP6P9b.
4.4 | The 6.5-kb SV aggravates the loss of 
efficacy of insecticide-treated nets
The design of the simple PCR-based assay to genotype the 6.5-kb 
SV enabled us to assess the impact of such structural variation on 
the efficacy of insecticide-treated nets, including the pyrethroid-
only and the PBO-synergist nets. The greater reduction of efficacy 
that the 6.5-kb SV was shown to cause on pyrethroid-only nets than 
PBO-based nets is similar to that observed with CYP6P9a (Weedall 
et al., 2019) and CYP6P9b (Mugenzi et al., 2019) in terms of reduction 
of mortality rate and blood-feeding inhibition. It further supports the 
view that PBO-based nets should be deployed to control P450-based 
metabolically resistant mosquito populations such as A. funestus 
throughout southern Africa. The fact that triple homozygous resist-
ant mosquitoes have a greater ability to survive exposure to LLINs 
shows that resistance escalation in field populations of vectors is 
likely to significantly reduce the effectiveness of current pyrethroid-
based LLINs. If such resistance escalation involves mechanisms other 
than just P450s, it could further reduce the efficacy of LLINs, as re-
cently shown for a population of A. funestus in southern Mozambique 
which was even able to survive exposure to some PBO-based nets 
(Riveron et al., 2019) due partially to over-expression of CYP6P9a and 
CYP6P9b and the fixation of all three resistance alleles (6.5-kb SV, 
CYP6P9a-R and CYP6P9b-R) but probably also other mechanisms yet 
to be elucidated. The availability of additional DNA-based markers 
such as these will now enable control programmes to assess how re-
sistance is impacting the efficacy of the bed nets in their country and 
decide whether to adopt PBO-based nets or even new generation 
nets with classes of insecticide other than just pyrethroids.
In conclusion, by elucidating the role of a 6.5-kb SV in the py-
rethroid resistance in A. funestus, this study has highlighted the im-
portant contribution of SVs in cis-regulatory regions in metabolic 
resistance in mosquitoes. It also highlighted the role of enhancers 
in the over-expression of metabolic resistance genes. This study 
designed a simple molecular diagnostic assay to easily monitor this 
P450-based metabolic resistance in wild populations. The additive 
resistance confers by this 6.5-kb SV in the presence of cis-regulatory 
promoter factors at CYP6P9a and CYP6P9b as well as allelic variation 
in coding regions (Ibrahim et al., 2015) highlights the complex array 
of evolutionary tools that mosquitoes deploy to survive the scale-up 
of insecticide-based control interventions such as LLINs. The near 
fixation of triple resistance (SV/CYP6P9a/CYP6P9b) in southern 
Africa calls for urgent action by using insecticides other than pyre-
throids for indoor residual spray (IRS) and new generation LLINs with 
PBO and preferably with a new insecticide class.
ACKNOWLEDG MENTS
The authors thank the inhabitants of Mibellon for their support 
during the study. This work was supported by Wellcome Trust 
Senior Research Fellowship in Biomedical Sciences to CS.W. 
(101893/Z/13/Z and 217188/Z/19/Z).
CONFLIC TS OF INTERE S T
The authors declare that they have no competing interests.
AUTHOR CONTRIBUTIONS
C.S.W. conceived the study; C.S.W. and F.C.N. designed the study; 
G.D.W. and C.S.W. analysed the next-generation sequencing data 
with assistance from J.H., M.J.W., J.M.R. and M.T., L.M.J.M. and 
C.S.W. characterized the CYP6P9a/b intergenic region and designed 
the PCR diagnostic assay; L.M.J.M. and M.T. generated the laboratory 
crosses and performed the validation of the PCR; L.M.J.M. performed 
the qRT-PCR. B.D.M. performed the experimental hut experiments 
with C.S.W. and genotyped the 6.5-kb structural variant with M.J.W. 
and M.T.; C.S.W. and L.M.J.M. wrote the paper with assistance from 
J.H.; all authors read and approved the final draft of the paper.
DATA AVAIL ABILIT Y S TATEMENT
All genomic data sets are available from the European Nucleotide 
Archive. Pooled template whole-genome sequencing data are 
available under study accessions PRJEB13485 (Malawi 2002 and 
Malawi 2014), PRJEB24384 (Ghana, Benin, Cameroon and Uganda) 
and PRJEB35040 (Mozambique 2002, 2016; DRC-Kinshasa and 
Mikalayi).
4410  |     MUGENZI Et al.
ORCID
Leon M. J. Mugenzi  https://orcid.org/0000-0002-6857-9608 
Jack Hearn  https://orcid.org/0000-0003-3358-4949 
R E FE R E N C E S
Amenya, D., Naguran, R., Lo, T.-C.-M., Ranson, H., Spillings, B. L., Wood, O. 
R., Brooke, B. D., Coetzee, M., & Koekemoer, L. L. (2008). Over expres-
sion of a cytochrome P450 (CYP6P9) in a major African malaria vector, 
Anopheles funestus, resistant to pyrethroids. Insect Molecular Biology, 
17(1), 19–25. https://doi.org/10.1111/j.1365-2583.2008.00776.x
Barnes, K. G., Irving, H., Chiumia, M., Mzilahowa, T., Coleman, M., 
Hemingway, J., & Wondji, C. S. (2017). Restriction to gene flow is as-
sociated with changes in the molecular basis of pyrethroid resistance 
in the malaria vector Anopheles funestus. Proceedings of the National 
Academy of Sciences of the United States of America, 114(2), 286–291. 
https://doi.org/10.1073/pnas.16154 58114
Barnes, K. G., Weedall, G. D., Ndula, M., Irving, H., Mzihalowa, T., 
Hemingway, J., & Wondji, C. S. (2017). Genomic footprints of se-
lective sweeps from metabolic resistance to pyrethroids in African 
malaria vectors are driven by scale up of insecticide-based vector 
control. PLoS Genetics, 13(2), e1006539. https://doi.org/10.1371/
journ al.pgen.1006539
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, 
U., Battle, K., Moyes, C. L., Henry, A., Eckhoff, P. A., Wenger, E. A., 
Briët, O., Penny, M. A., Smith, T. A., Bennett, A., Yukich, J., Eisele, 
T. P., Griffin, J. T., Fergus, C. A., … Gething, P. W. (2015). The effect 
of malaria control on Plasmodium falciparum in Africa between 2000 
and 2015. Nature, 526(7572), 207–211.
Catania, F., Kauer, M., Daborn, P., Yen, J., Ffrench-Constant, R., 
& Schlötterer, C. (2004). World-wide survey of an Accord in-
sertion and its association with DDT resistance in Drosophila 
melanogaster. Molecular Ecology, 13(8), 2491–2504. https://doi.
org/10.1111/j.1365-294X.2004.02263.x
Chung, H., Bogwitz, M. R., McCart, C., Andrianopoulos, A., Batterham, 
P., & Daborn, P. J. (2007). Cis-regulatory elements in the Accord ret-
rotransposon result in tissue-specific expression of the Drosophila 
melanogaster insecticide resistance gene Cyp6g1. Genetics, 175(3), 
1071–1077.
Daborn, P. J., Yen, J. L., Bogwitz, M. R., Le Goff, G., Feil, E., Jeffers, S., 
Tijet, N., Perry, T., Heckel, D., Batterham, P., Feyereisen, R., Wilson, 
T. G., & ffrench-Constant, R. H. (2002). A single P450 allele asso-
ciated with insecticide resistance in Drosophila. Science, 297(5590), 
2253–2256.
Dickel, D. E., Visel, A., & Pennacchio, L. A. (2013). Functional anatomy 
of distant-acting mammalian enhancers. Philosophical Transactions of 
the Royal Society of London. Series B, Biological Sciences, 368(1620), 
20120359. https://doi.org/10.1098/rstb.2012.0359
Hall, T. A. (1999). BioEdit: A user-friendly biological sequence alignment ed-
itor and analysis program for Windows 95/98/NT. Paper presented at 
the Nucleic acids symposium series.
Hemingway, J., & Ranson, H. (2000). Insecticide resistance in insect vec-
tors of human disease. Annual Review of Entomology, 45(1), 371–391. 
https://doi.org/10.1146/annur ev.ento.45.1.371
Hunt, R., Brooke, B., Pillay, C., Koekemoer, L., & Coetzee, M. 
(2005). Laboratory selection for and characteristics of py-
rethroid resistance in the malaria vector Anopheles funestus. 
Medical and Veterinary Entomology, 19(3), 271–275. https://doi.
org/10.1111/j.1365-2915.2005.00574.x
Ibrahim, S. S., Ndula, M., Riveron, J. M., Irving, H., & Wondji, C. S. (2016). 
The P450 CYP6Z1 confers carbamate/pyrethroid cross-resistance in 
a major African malaria vector beside a novel carbamate-insensitive 
N485I acetylcholinesterase-1 mutation. Molecular Ecology, 25(14), 
3436–3452. https://doi.org/10.1111/mec.13673
Ibrahim, S. S., Riveron, J. M., Bibby, J., Irving, H., Yunta, C., Paine, M. 
J., & Wondji, C. S. (2015). Allelic variation of cytochrome P450s 
drives resistance to Bednet insecticides in a major malaria vector. 
PLoS Genetics, 11(10), e1005618. https://doi.org/10.1371/journ 
al.pgen.1005618
Ingham, V. A., Pignatelli, P., Moore, J. D., Wagstaff, S., & Ranson, H. 
(2017). The transcription factor Maf-S regulates metabolic resis-
tance to insecticides in the malaria vector Anopheles gambiae. BMC 
Genomics, 18(1), 669. https://doi.org/10.1186/s1286 4-017-4086-7
Irving, H., & Wondji, C. S. (2017). Investigating knockdown resistance 
(kdr) mechanism against pyrethroids/DDT in the malaria vector 
Anopheles funestus across Africa. BMC Genetics, 18(1), 76. https://doi.
org/10.1186/s1286 3-017-0539-x
Langmead, B., & Salzberg, S. L. (2012). Fast gapped-read alignment with 
Bowtie 2. Nature Methods, 9(4), 357–359. https://doi.org/10.1038/
nmeth.1923
Livak, K. J. (1984). Organization and mapping of a sequence on the 
Drosophila melanogaster X and Y chromosomes that is transcribed 
during spermatogenesis. Genetics, 107(4), 611–634.
Lucas, E. R., Miles, A., Harding, N. J., Clarkson, C. S., Lawniczak, M. K., 
Kwiatkowski, D. P., Weetman, D., & Donnelly, M. J., & Anopheles 
gambiae 1000 Genomes Consortium (2019). Whole-genome se-
quencing reveals high complexity of copy number variation at insec-
ticide resistance loci in malaria mosquitoes. Genome Research, 29(8), 
1250–1261. https://doi.org/10.1101/gr.245795.118
Lumjuan, N., Rajatileka, S., Changsom, D., Wicheer, J., Leelapat, P., 
Prapanthadara, L.-A., Somboon, P., Lycett, G., & Ranson, H. (2011). 
The role of the Aedes aegypti Epsilon glutathione transferases in 
conferring resistance to DDT and pyrethroid insecticides. Insect 
Biochemistry and Molecular Biology, 41(3), 203–209. https://doi.
org/10.1016/j.ibmb.2010.12.005
Martinez-Torres, D., Chandre, F., Williamson, M. S., Darriet, F., Bergé, J. B., 
Devonshire, A. L., Guillet, P., Pasteur, N., & Pauron, D. (1998). Molecular 
characterization of pyrethroid knockdown resistance (kdr) in the 
major malaria vector Anopheles gambiae ss. Insect Molecular Biology, 
7(2), 179–184. https://doi.org/10.1046/j.1365-2583.1998.72062.x
Michel, A. P., Ingrasci, M. J., Schemerhorn, B. J., Kern, M., Le Goff, 
G., Coetzee, M., Elissa, N., Fontenille, D., Vulule, J., Lehmann, T., 
Sagnon, N. F., Costantini, C., & Besansky, N. J. (2005). Rangewide 
population genetic structure of the African malaria vector Anopheles 
funestus. Molecular Ecology, 14(14), 4235–4248. https://doi.
org/10.1111/j.1365-294X.2005.02754.x
Mitchell, S. N., Stevenson, B. J., Müller, P., Wilding, C. S., Egyir-Yawson, A., Field, 
S. G., Hemingway, J., Paine, M. J. I., Ranson, H., & Donnelly, M. J. (2012). 
Identification and validation of a gene causing cross-resistance between 
insecticide classes in Anopheles gambiae from Ghana. Proceedings of the 
National Academy of Sciences of the United States of America, 109(16), 
6147–6152. https://doi.org/10.1073/pnas.12034 52109
Mugenzi, L. M., Menze, B. D., Tchouakui, M., Wondji, M. J., Irving, H., 
Tchoupo, M., Hearn, J., Weedall, G. D., Riveron, J. M., & Wondji, C. S. 
(2019). Cis-regulatory CYP6P9b P450 variants associated with loss 
of insecticide-treated bed net efficacy against Anopheles funestus. 
Nature Communications, 10(1), 1–11.
Nardini, L., Holm, I., Pain, A., Bischoff, E., Gohl, D. M., Zongo, S., 
Guelbeogo, W. M., Sagnon, N., Vernick, K. D., & Riehle, M. M. (2019). 
Influence of genetic polymorphism on transcriptional enhancer ac-
tivity in the malaria vector Anopheles coluzzii. Scientific Reports, 9(1), 
1–14. https://doi.org/10.1038/s4159 8-019-51730 -8
Pennacchio, L. A., Bickmore, W., Dean, A., Nobrega, M. A., & Bejerano, G. 
(2013). Enhancers: Five essential questions. Nature Reviews Genetics, 
14(4), 288–295. https://doi.org/10.1038/nrg3458
Riveron, J. M., Chiumia, M., Menze, B. D., Barnes, K. G., Irving, H., Ibrahim, 
S. S., Weedall, G. D., Mzilahowa, T., & Wondji, C. S. (2015). Rise of 
multiple insecticide resistance in Anopheles funestus in Malawi: A 
     |  4411MUGENZI Et al.
major concern for malaria vector control. Malaria Journal, 14(1), 344. 
https://doi.org/10.1186/s1293 6-015-0877-y
Riveron, J. M., Huijben, S., Tchapga, W., Tchouakui, M., Wondji, M. J., 
Tchoupo, M., Irving, H., Cuamba, N., Maquina, M., Paaijmans, K., & 
Wondji, C. S. (2019). Escalation of pyrethroid resistance in the ma-
laria vector Anopheles funestus induces a loss of efficacy of PBO-
based insecticide-treated nets in Mozambique. Journal of Infectious 
Diseases, 220, 467–475. https://doi.org/10.1093/infdi s/jiz139
Riveron, J. M., Ibrahim, S. S., Mulamba, C., Djouaka, R., Irving, H., Wondji, 
M. J., Ishak, I. H., & Wondji, C. S. (2017). Genome-wide transcription 
and functional analyses reveal heterogeneous molecular mechanisms 
driving pyrethroids resistance in the major malaria vector Anopheles 
funestus across Africa. G3: Genes, Genomes, Genetics, 7, 1819–1832.
Riveron, J. M., Irving, H., Ndula, M., Barnes, K. G., Ibrahim, S. S., Paine, M. 
J., & Wondji, C. S. (2013). Directionally selected cytochrome P450 al-
leles are driving the spread of pyrethroid resistance in the major ma-
laria vector Anopheles funestus. Proceedings of the National Academy 
of Sciences of the United States of America, 110(1), 252–257. https://
doi.org/10.1073/pnas.12167 05110
Riveron, J. M., Yunta, C., Ibrahim, S. S., Djouaka, R., Irving, H., Menze, 
B. D., Ismail, H. M., Hemingway, J., Ranson, H., Albert, A., & Wondji, 
C. S. (2014). A single mutation in the GSTe2 gene allows track-
ing of metabolically-based insecticide resistance in a major ma-
laria vector. Genome Biology, 15(2), R27. https://doi.org/10.1186/
gb-2014-15-2-r27
Weedall, G. D., Mugenzi, L. M. J., Menze, B. D., Tchouakui, M., Ibrahim, S. 
S., Amvongo-Adjia, N., Irving, H., Wondji, M. J., Tchoupo, M., Djouaka, 
R., Riveron, J. M., & Wondji, C. S. (2019). A cytochrome P450 allele 
confers pyrethroid resistance on a major African malaria vector, 
reducing insecticide-treated bednet efficacy. Science Translational 
Medicine, 11(484), eaat7386.
Weedall, G. D., Riveron, J. M., Hearn, J., Irving, H., Kamdem, C., Fouet, C., 
White, B. J., & Wondji, C. S. (2020). An Africa-wide genomic evolu-
tion of insecticide resistance in the malaria vector Anopheles funestus 
involves selective sweeps, copy number variations, gene conversion 
and transposons. PLoS Genetics, 16(6), e1008822.
Wei, Z., Wang, W., Hu, P., Lyon, G. J., & Hakonarson, H. (2011). SNVer: 
A statistical tool for variant calling in analysis of pooled or individ-
ual next-generation sequencing data. Nucleic Acids Research, 39(19), 
e132. https://doi.org/10.1093/nar/gkr599
WHO (2012). Global plan for insecticide resistance management in ma-
laria vectors: executive summary, Geneva, Switzerland:  World Health 
Organization. Retrieved from https://apps.who.int/iris/handl 
e/10665/ 44846
WHO (2013). Malaria entomology and vector control, Geneva, Switzerland:. 
World Health Organization. https://www.who.int/malar ia/publi catio 
ns/atoz/97892 41505 819/en/
WHO (2018). World malaria report 2018,  Geneva, Switzerland: World 
Health Organization. https://www.who.int/malar ia/publi catio ns/
world -malar ia-repor t-2018/en/
WHO (2019). World malaria report 2019,  Geneva, Switzerland: World 
Health Organization. https://www.who.int/publi catio ns-detai l-redir 
ect/97892 41565721
Wilding, C. S., Smith, I., Lynd, A., Yawson, A. E., Weetman, D., Paine, M. J., 
& Donnelly, M. J. (2012). A cis-regulatory sequence driving metabolic 
insecticide resistance in mosquitoes: Functional characterisation 
and signatures of selection. Insect Biochemistry and Molecular Biology, 
42(9), 699–707. https://doi.org/10.1016/j.ibmb.2012.06.003
Wondji, C. S., Dabire, R. K., Tukur, Z., Irving, H., Djouaka, R., & Morgan, 
J. C. (2011). Identification and distribution of a GABA receptor mu-
tation conferring dieldrin resistance in the malaria vector Anopheles 
funestus in Africa. Insect Biochemistry and Molecular Biology, 41(7), 
484–491.
Wondji, C. S., Irving, H., Morgan, J., Lobo, N. F., Collins, F. H., Hunt, R. 
H., Coetzee, M., Hemingway, J., & Ranson, H. (2009). Two duplicated 
P450 genes are associated with pyrethroid resistance in Anopheles 
funestus, a major malaria vector. Genome Research, 19, 452–459.
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting Information section.
How to cite this article: Mugenzi LMJ, Menze BD, Tchouakui 
M, et al. A 6.5-kb intergenic structural variation enhances 
P450-mediated resistance to pyrethroids in malaria vectors 
lowering bed net efficacy. Mol Ecol 2020;29:4395–4411. 
https://doi.org/10.1111/mec.15645
